Log in to save to my catalogue

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chem...

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chem...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_81ca3358e5a342b8bac0372a67c0f3f8

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy

About this item

Full title

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy

Publisher

Tokyo: John Wiley & Sons, Inc

Journal title

DEN Open, 2023-04, Vol.3 (1), p.e152-n/a

Language

English

Formats

Publication information

Publisher

Tokyo: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Objective
Endoscopic ultrasound (US)‐guided radiofrequency ablation (RFA) has been investigated for pancreatic ductal adenocarcinoma (PDAC) but studies are limited and heterogeneous. Computed tomography (CT) scan features may predict RFA response after chemotherapy but their role is unexplored. The primary aim was to investigate the efficacy of...

Alternative Titles

Full title

Ex‐vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_81ca3358e5a342b8bac0372a67c0f3f8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_81ca3358e5a342b8bac0372a67c0f3f8

Other Identifiers

ISSN

2692-4609

E-ISSN

2692-4609

DOI

10.1002/deo2.152

How to access this item